Fig. 1From: GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trialTrial flow diagram. BM Bone marrow, CLL Chronic lymphocytic leukaemia, CTRU Leeds Clinical Trials Research Unit, HMDS Haematological Malignancy Diagnostic Service, MRD Minimal residual disease, QoL Quality of lifeBack to article page